Asston Pharmaceuticals has scheduled a board meeting for September 4, 2026, to approve remuneration increases for its managing director and whole-time director. The session will also finalize the appointment of the company’s statutory auditor.

The board intends to review and approve the appointment of M/s Panchal S K & Associates as the statutory auditor. The firm holds Peer Review Certificate No. 018089 and Firm Registration No. 145989W.

Key Agenda Items

The meeting agenda focuses on governance adjustments and compensation reviews for senior leadership. Key decisions include:

• Increase in remuneration for Ashish Narayan Sakalkar, Managing Director.
• Increase in remuneration for Saili Jayaram More, Whole Time Director and CEO.
• Increase in remuneration for Sachin Chandrakant Badakh, Non-Executive Director.

The board will also ascertain the directors retiring by rotation and approve the date and draft notice for the company’s seventh Annual General Meeting.

Regulatory Compliance

The intimation was issued pursuant to Regulation 29(1) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Rishi Upadhaya, Company Secretary & Compliance Officer, signed the disclosure on August 27, 2026.

Asston Pharmaceuticals secured unanimous shareholder approval for a special resolution to issue equity shares on a preferential basis at its Extraordinary General Meeting (EGM) held on July 31, 2026. The resolution passed with 100% of the votes polled, totaling 4,682,584 votes in favor and zero against, clearing the path for the company to execute the capital raise as planned. This outcome confirms strong backing from both promoter and public shareholders for the strategic move.

The EGM was conducted via Video Conferencing/Other Audio Visual Means (OAVM), commencing at 12:30 P.M. and concluding at 12:51 P.M. Mr. Ashish Narayan Sakalkar, Managing Director, chaired the meeting after being appointed Chairman by the members. The requisite quorum was present throughout the proceedings, ensuring compliance with the Companies Act, 2013. Shareholders exercised their voting rights through remote e-voting facilitated by National Securities Depository Limited (NSDL), with the voting window open from July 28, 2026, to July 31, 2026.

Ms. Pragya Jain of M/s Pragya & Associates served as the independent Scrutinizer, appointed by the Board to oversee the fairness and transparency of the e-voting process. Her report, dated August 3, 2026, confirmed that the electronic data generated by NSDL was scrutinized on a test-check basis and relied upon for the final results. M/s Panchal SK and Associates acted as the Statutory Auditor during the proceedings.

Voting Breakdown

The voting results reveal distinct participation patterns between promoter and public shareholders. Promoter group members, holding 4,312,480 shares, participated fully via e-voting, casting all their votes in favor of the resolution. In contrast, public non-institutional shareholders, holding 4,199,880 shares, had a lower participation rate, with only 370,104 votes polled. However, those who did vote supported the resolution unanimously.

No invalid votes were recorded across any category. The record date for determining eligibility to vote was July 24, 2026, with 727 shareholders on record. Of these, three promoter shareholders and seven public shareholders attended the meeting virtually.

Key Attendees

The following directors and key managerial personnel attended the virtual meeting:

• Ashish Narayan Sakalkar, Managing Director
• Saili Jayaram More, Whole Time Director and CEO
• Rishabh Kumar Jain, Independent Director
• Sachin Chandrakant Badakh, Non-Executive Director
• Sandip Sharma, Independent Director
• Vijaya E Shahapurkar, Independent Director
• Yashvardhan Nitin Tupe, Non-Executive Director
• Yogesh Prakesh Supekar, Non-Executive Director

Regulatory Compliance

The company submitted the Scrutinizer’s Report along with the voting results to BSE Limited on August 3, 2026, in compliance with Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The submission was signed by Rishi Upadhaya, Company Secretary and Compliance Officer. The promoters declared no interest in the agenda item, confirming that the preferential issue is not directed towards them but likely towards third-party investors or strategic partners, although specific allotment details were not disclosed in the filing.